523 reports of this reaction
3.4% of all BUPIVACAINE reports
#4 most reported adverse reaction
HYPOTENSION is the #4 most commonly reported adverse reaction for BUPIVACAINE, manufactured by Pacira Pharmaceuticals, Inc.. There are 523 FDA adverse event reports linking BUPIVACAINE to HYPOTENSION. This represents approximately 3.4% of all 15,404 adverse event reports for this drug.
Patients taking BUPIVACAINE who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among BUPIVACAINE users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for BUPIVACAINE:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 523 FDA reports for BUPIVACAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 3.4% of all adverse event reports for BUPIVACAINE, making it a notable side effect.
If you experience hypotension while taking BUPIVACAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.